SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-762737
Filing Date
2016-11-08
Accepted
2016-11-08 13:05:33
Documents
2
Period of Report
2016-10-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d244547d8k.htm 8-K 14388
2 EX-3.1 d244547dex31.htm EX-3.1 290633
  Complete submission text file 0001193125-16-762737.txt   306143
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 161980614
SIC: 2836 Biological Products, (No Diagnostic Substances)